Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Learn ways to generate income quickly with effective strategies. These tips will help you boost your earnings in no time.
21,313 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
eXp World Holdings posts strong first-quarter results as agent productivity rises and it taps NextHome to broaden its...
The SpaceX IPO is stirring big hype, but not every spark is a signal to buy. This guide explains the worst reason spa...
Groupon is charting a new path in local commerce as 2025 earnings loom. This guide breaks down the drivers, risks, an...
SoFi stock has faced a meaningful hurdle in 2026. This guide breaks down whether the decline represents a temporary s...
The race to a cleaner power grid is accelerating. Projected annual global renewable energy investment could reach $2....
Warren Buffett has long warned that cash can be a dangerous long-term asset. This article breaks down the risk Warren...
The first watch restaurant stock has cooled off after a strong earnings showing, but the story isn’t just about numbe...
This article breaks down MSGM earnings and what investors should watch in motorsport games. Learn how revenue streams...
Micron Technology stands out in a complex memory market. This article breaks down three practical reasons micron bril...
A major institutional purchase in an international rotation ETF has market watchers buzzing. This article unpacks wha...
As AI reshapes the job market and tuition costs rise, the debate over whether the college degree still worth the cost...